Abstract
Generics (UK) Ltd (t/a Mylan) v Yeda Research and Development Company Ltd [2017] EWHC 2629 (Pat), High Court of England and Wales, 26 October 2017 In light of the recent Supreme Court decision in Actavis UK Ltd v Eli Lilly and Co [2017] UKSC 48, the Patents Court has considered the correct approach to the interpretation of patent claims and Mr Justice Arnold has held that the doctrine of equivalents does not apply when assessing novelty.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Intellectual Property Law & Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
